Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 20, 2014

Primary Completion Date

June 27, 2015

Study Completion Date

October 17, 2015

Conditions

Diabetic Foot Ulcer

Interventions

DRUG

Esmolol hydrochloride

DRUG

Esmolol hydrochloride

DRUG

Esmolol hydrochloride

DRUG

Placebo gel

Trial Locations (5)

S.L. Raheja Hospital, Mumbai

Deenanath Mangeshkar Hospital & Research Center, Pune

VA New England Health Care Division, Providence

M V Hospital for Diabetes Pvt. Ltd., Chennai

Hospital Kuala Lumpur, Kuala Lumpur

All Listed Sponsors

lead

Novalead Pharma Private Limited

INDUSTRY

NCT01113515 - Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter